# Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism

> **NCT01107067** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 32 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Sustanon

## Key facts

- **NCT ID:** NCT01107067
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107067, "Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01107067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*